Eukles Asset Management Raises Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD

published 31.07.2020 15:38

Image of article 'Eukles Asset Management Raises Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD'

Eukles Asset Management lifted its holdings in Gilead Sciences, Inc. (NASDAQ:GILD) by 7.1% in the second quarter, according to the company in its most recent disclosure with the SEC.

The institutional investor owned 13,538 shares of the biopharmaceutical company’s stock after purchasing an additional 895 shares during the quarter.

Guggenheim Capital LLC now owns 917,971 shares of the biopharmaceutical company’s stock valued at $59,650,000 after buying an additional 78,152 shares in the last quarter.

Sontag Advisory LLC now owns 17,971 shares of the biopharmaceutical company’s stock valued at $1,344,000 after purchasing an additional 12,644 shares during the last quarter.

Commerzbank Aktiengesellschaft FI now owns 198,441 shares of the biopharmaceutical company’s stock valued at $14,835,000 after purchasing an additional 2,557 shares during the last quarter.

by Donna Brown from theolympiareport.com

Free awesomeness straight to your inbox!

Sign up now for this free newsletter to receive hand picked content, covering topics like Lifestyle, Business & Technology.

Free Newsletter Sign up now!

..or jump directly to the latest posts!